A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
Krarup, A., Truan, D., Furmanova-Hollenstein, P., Bogaert, L., Bouchier, P., Bisschop, I.J., Widjojoatmodjo, M.N., Zahn, R., Schuitemaker, H., McLellan, J.S., Langedijk, J.P.(2015) Nat Commun 6: 8143-8143
- PubMed: 26333350 
- DOI: 10.1038/ncomms9143
- Primary Citation of Related Structures:  
5C69, 5C6B - PubMed Abstract: 
Respiratory syncytial virus (RSV) causes acute lower respiratory tract infections and is the leading cause of infant hospitalizations. Recently, a promising vaccine antigen based on the RSV fusion protein (RSV F) stabilized in the native prefusion conformation has been described ...